Date |
Time |
Source |
Heading |
4/25/2024 | 8:52 | IHNW | FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA |
4/24/2024 | 16:30 | GLOBE | IO Biotech Announces Abstract Accepted for Presentation at.. |
4/15/2024 | 08:30 | GLOBE | IO Biotech Expands Senior Leadership Team to Progress.. |
4/09/2024 | 12:00 | GLOBE | IO Biotech Presents New Data at AACR 2024 Further Supporting.. |
4/05/2024 | 08:30 | GLOBE | IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business.. |
3/11/2024 | 16:56 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
3/06/2024 | 16:11 | GLOBE | IO Biotech Announces Acceptance of Abstract to be Presented.. |
3/05/2024 | 17:17 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
3/05/2024 | 16:46 | EDGAR2 | Form 8-K - Current report |
3/05/2024 | 16:40 | GLOBE | IO Biotech Announces 2023 Fourth-Quarter and Year-End.. |
2/26/2024 | 16:05 | GLOBE | IO Biotech to Present at 44th Annual Cowen Health Care.. |
1/08/2024 | 08:11 | EDGAR2 | Form 8-K - Current report |
12/21/2023 | 08:30 | GLOBE | IO Biotech Announces First Patient Dosed in Phase 2.. |
11/24/2023 | 17:37 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
11/13/2023 | 16:15 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
11/13/2023 | 08:12 | GLOBE | IO Biotech Announces 2023 Third Quarter Results |
11/13/2023 | 08:10 | EDGAR2 | Form 8-K - Current report |
11/13/2023 | 08:00 | GLOBE | IO Biotech Appoints Helen Collins, MD, to its Board of.. |
11/10/2023 | 08:00 | GLOBE | IO Biotech Completes Enrollment of 380 Patients in Pivotal.. |
11/08/2023 | 16:30 | GLOBE | IO Biotech Announces Participation in Upcoming Investor.. |
11/01/2023 | 08:30 | GLOBE | IO Biotech Presents Three Posters at the Society for.. |
10/23/2023 | 01:00 | GLOBE | Encouraging Preliminary Data from a Phase 2 Trial Evaluating.. |
10/03/2023 | 16:30 | GLOBE | IO Biotech Announces Three Poster Presentations at the.. |
9/12/2023 | 16:06 | EDGAR2 | Form 424B2 - Prospectus [Rule 424(b)(2)] |
9/12/2023 | 08:05 | GLOBE | IO Biotech Announces New Data Related to its IO102-IO103.. |
9/11/2023 | 00:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
9/07/2023 | 10:36 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
9/06/2023 | 08:35 | GLOBE | IO Biotech Announces Participation in Upcoming Investor.. |
8/30/2023 | 16:16 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
8/15/2023 | 18:02 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
8/15/2023 | 17:57 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
8/11/2023 | 21:24 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
8/11/2023 | 08:41 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
8/11/2023 | 08:31 | EDGAR2 | Form 8-K - Current report |
8/11/2023 | 08:30 | GLOBE | IO Biotech Announces 2023 Second Quarter Results |
8/11/2023 | 08:05 | GLOBE | IO Biotech Appoints Heidi Hunter to its Board of Directors |
8/09/2023 | 20:43 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
8/09/2023 | 20:41 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
8/08/2023 | 08:05 | GLOBE | IO Biotech Announces Abstract Accepted for Poster.. |
8/07/2023 | 08:31 | EDGAR2 | Form 8-K - Current report |
8/07/2023 | 08:30 | GLOBE | IO Biotech, Inc. Announces $75 Million Private Placement.. |
7/28/2023 | 08:05 | GLOBE | IO Biotech Announces First Patient Dosed in.. |
7/25/2023 | 16:05 | GLOBE | IO Biotech Announces Abstract Accepted for Mini Oral.. |
7/19/2023 | 16:20 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
7/19/2023 | 16:10 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
7/18/2023 | 16:05 | EDGAR2 | Form 8-K - Current report |
7/18/2023 | 16:05 | GLOBE | IO Biotech Strengthens Executive Management and US Presence.. |
6/14/2023 | 08:00 | GLOBE | IO Biotech Announces Achievement of Significant Phase 3.. |
6/01/2023 | 08:30 | GLOBE | IO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior.. |